Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

3.4K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.4K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

5.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
5.1K
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

870
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
870
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

2.2K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.2K
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

3.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
3.2K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

4.1K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
4.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Support needs and non-pharmacological interventions for adults with mixed connective tissue disease: a systematic literature review.

EULAR rheumatology open·2026
Same author

Healthcare providers' awareness and knowledge of recommendations on cardiovascular risk management in people with rheumatic and musculoskeletal diseases: a survey study.

EULAR rheumatology open·2026
Same author

Announcing The Lancet Rheumatology commission on reproductive health and family planning in immune-mediated long-term conditions: empowering special reproductive journeys.

The Lancet. Rheumatology·2026
Same author

Comparison of BAFF and type I IFN activity in blood and placenta in SLE and healthy pregnancies.

Lupus science & medicine·2026
Same author

Therapeutic Interventions for Obstetric Antiphospholipid Syndrome Associated with Recurrent Pregnancy Loss: A Scoping Review of Randomized Controlled Trials on Live Birth Outcomes.

Seminars in thrombosis and hemostasis·2026
Same author

Lectin pathway of complement in SLE: MAP-1 as a marker of haematological manifestations and elevated type I interferon activity.

Lupus science & medicine·2026

Related Experiment Video

Updated: Apr 2, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

21.1K

Pulmonary diseases in SLE: a population-based cross-sectional study.

Henrik Zachar Langkilde1, Jesper Davidsen2,3, Stefan Harders4

  • 1Research Unit of Rheumatology, Department of Clinical Research, University of Southern Denmark, Odense University Hospital, Odense, Denmark henrik.zachar.langkilde@rsyd.dk.

Lupus Science & Medicine
|March 31, 2026
PubMed
Summary
This summary is machine-generated.

Pulmonary diseases (PDs) affect 59% of patients with Systemic Lupus Erythematosus (SLE) and are linked to reduced lung function. Diagnosing PD in SLE patients is challenging, often requiring advanced imaging like HRCT.

Keywords:
PrevalencePulmonary FibrosisSystemic Lupus Erythematosus

More Related Videos

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

950
Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

3.6K

Related Experiment Videos

Last Updated: Apr 2, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

21.1K
Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

950
Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

3.6K

Area of Science:

  • Rheumatology
  • Pulmonology
  • Radiology

Background:

  • Pulmonary diseases (PDs) are common in Systemic Lupus Erythematosus (SLE) but diagnosis is challenging.
  • Previous prevalence estimates for PD in SLE vary widely (30-98%).
  • A population-based study is needed to accurately determine PD prevalence in SLE.

Purpose of the Study:

  • Determine the prevalence of PD in SLE patients.
  • Investigate the prevalence of specific PD subtypes in SLE.
  • Assess pulmonary function and its association with PD in SLE.
  • Explore associations between patient characteristics and PD in SLE.

Main Methods:

  • Population-based cross-sectional study in Region Southern Denmark.
  • Included adult SLE patients meeting classification criteria.
  • Utilized clinical assessment, pulmonary function tests (PFTs), and chest high-resolution CT (HRCT).
  • Multidisciplinary discussion for PD and subtype diagnosis.

Main Results:

  • PDs were found in 59% of 185 SLE patients.
  • Prevalence of subtypes: interstitial lung diseases (12%), pleural diseases (19%), airway diseases (38%).
  • PD associated with decreased pulmonary function, but PFTs had low diagnostic utility.
  • No strong associations found between patient characteristics and PD presence.

Conclusions:

  • 59% of SLE patients have PD, impacting pulmonary function.
  • Clinical assessment and PFTs have limited value for diagnosing PD in SLE.
  • HRCT and other specialized investigations are often necessary for accurate diagnosis.